KAYLA RICHOUX: Open Payments
NPI 1962910836 · PORT ALLEN, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,310 in 93 payments from 17 companies in 2025. Trend: 2023 $1,409 · 2024 $1,143 · 2025 $1,310
Food & beverage: $1,310
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $279 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $183 |
| Paratek Pharmaceuticals, Inc. | 2 | $137 |
| Novo Nordisk Inc | 11 | $135 |
| Axsome Therapeutics, Inc. | 3 | $74 |
| Corium, LLC | 6 | $73 |
| Abbott Laboratories | 3 | $64 |
| Phathom Pharmaceuticals, Inc. | 10 | $55 |
| Esperion Therapeutics, Inc. | 3 | $48 |
| PFIZER INC. | 2 | $45 |
Products named: Kerendia, VRAYLAR, NUZYRA, UBRELVY, Auvelity, Azstarys, FREESTYLE LIBRE 3, VOQUEZNA.
Industry payments across LA — which companies pay providers there.
